Cartilage Repair/Regeneration Market Growth, Size, Share, Trends, and Forecast 2032

Industry Prospective:

The global Cartilage Repair/Regeneration Market was worth around USD 852.9 million in 2021 and is estimated to grow to about USD 1962.538958 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.9 percent over the forecast period. The report analyzes the digital remittance market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.

Cartilage Repair/Regeneration Market: Overview

Articular cartilage, which acts as a cushion between bone terminals, is replaced by cartilage regeneration. Bone collides with a bone when the cartilage is injured or worn down, generating pain near the sensitive nerve ends. Because cartilage lacks a blood supply, it has a limited ability to repair itself. The restoration of the cartilage (articular) surface of a joint that has been impacted by an osteochondral/chondral defect is referred to as cartilage repair. After an accident, the damaged joint normally swells up, and it might take weeks or even months for the swelling to subside. Articular cartilage is a defect produced by osteoarthritis, and because of its vascular structure and restricted mitotic capabilities, it is less important for any repairs. Movement constraints, muscle stiffness, soreness, inflammation, and physical disability are among the symptoms of cartilage loss.

Over the projected period, the cartilage repair market is expected to be governed by the rising prevalence of diabetes and obesity around the world. Diabetes leads to a greater loss of cartilage.

COVID-19 Impact:

During the first half of the projection period, the COVID-19 outbreak will have an influence on the cartilage repair and regeneration market. The cartilage repair and regeneration market are predicted to fall during the first portion of the forecasted period due to statewide lockdowns, denied wound care services, and canceled or postponed elective surgeries. However, demand for cartilage repair and regeneration products is predicted to skyrocket in the second half of the projection period.

Request Free Sample

Cartilage Repair/Regeneration Market: Growth Drivers

Increasing incidence of osteoarthritis

Osteoarthritis has become more common in recent years all around the world. According to a study undertaken by the University of North Carolina, around 1 million knee and hip replacement procedures are performed in the United States each year. The cost of osteoarthritis in the United States is 136.8 billion dollars per year. Degenerative joint illnesses, such as osteoarthritis, will impact more than 130 million people worldwide by 2050, according to the Arthritis Foundation.

Autologous chondrocyte implantation and Scaffolds implants are two of the most common therapies for osteoarthritis. As a result, demand for cartilage repair and regeneration products is predicted to rise as the prevalence of osteoarthritis rises.

Cartilage Repair/Regeneration Market: Restraints

High cost of cartilage repair surgeries

Even though cartilage repair procedures provide better and longer-lasting results than total knee replacement surgeries, the expense of these treatments is one of the key obstacles preventing patients from adopting them. Knee replacement treatments cost roughly USD 16,000 on average, while cartilage repair procedures cost between USD 18,000 and USD 23,000 on average, depending on the region where the procedure is performed. Because of the high prices, cartilage repair therapies are undervalued in comparison to knee replacement surgeries, resulting in a lower preference for these procedures.

Cartilage Repair/Regeneration Market: Segmentation

The global cartilage repair/regeneration market is segregated based on Treatment Modality, Application, Application Site, and End User.

By category, the market is classified into Hospitals, and Ambulatory Surgery Centers, and Clinics. The largest proportion of the cartilage repair and regeneration market was held by hospitals. This can be linked to the expanding number of hospitals in emerging nations and the large number of minimally invasive surgeries performed in hospitals.

By application site, the market is classified into Knee, Hip, Ankle and Foot, and Other Application Sites. In the worldwide cartilage repair and regeneration market, the knee segment accounted for the biggest share of the application site segment. This is due to an increase in the frequency of knee arthroscopy surgeries and the prevalence of knee osteoarthritis.

Report Scope:

Regional Landscape

Due to the high prevalence of osteoarthritis, the growing prevalence of sports injuries, and increased research funding in the US and Canada, North America accounted for the highest proportion of the cartilage repair and regeneration market. Furthermore, increased physician and patient awareness of innovative treatment techniques and technologies, as well as considerable government investments in Cartilage Repair/Regeneration technologies and therapies, are all helping the market's growth in North America. The Asia Pacific region is predicted to have a greater CAGR than other areas over the projection period. Furthermore, the increased prevalence of osteoporosis in Australia and New Zealand is resulting in an increase in cartilage injury, which is likely to accelerate the vertical's growth. In recent years, the markets in South America and the Middle East, and Africa (MEA) have been gradually expanding. These markets offer untapped potential due to a large population suffering from chronic joint and bone problems.

Competitive Landscape

Some of the main competitors dominating the global Cartilage Repair/Regeneration Market include - DePuy Synthes (US), Smith & Nephew plc (UK), Zimmer Biomet (US), CONMED Corporation (US), Stryker Corporation (US), and Vericel Corporation (US).

Global Cartilage Repair/Regeneration Market is segmented as follows:

By Treatment Modality

• Cell-based
• Non-cell-based

By Application

• Hyaline Cartilage
• Fibrocartilage

By Application Site

• Knee
• Hip
• Ankle and Foot
• Other Application Sites

By End User

• Hospitals
• Ambulatory Surgery Centers and Clinics

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa